“…However, little has been published on the effect of pharmacological immunosuppression in the control of immunological rejection phenomena in situ [22], With regard to CsA, although intrarenal deposits of this drug have been associated with morphological phe nomena of nephrotoxicity [16,[23][24][25], no detailed de scriptions have appeared on the influence of intrarenal CsA deposits on the inflammatory infiltrate in the rejec tion reaction. A previous study [16] found no relation between CsA deposits and CD8-positive cytotoxic sup pressor lymphocytes which have been associated with a poor prognosis [5,6,8], However, the occurrence in heart and pulmonary transplant patients of rejection reactions with a poor prognosis, probably related to CsA resistance phenomena in CD4-positive lymphocytes and/or macro phages [17,18], has opened new research avenues. Drugresistant rejection, like in the development of multidrug resistance in neoplastic cells [26,27], is linked with the expression of glycoprotein p-170.…”